drugset / Trial / NCT00143312
Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants
Non-randomizedSingle-groupOpen-labelPrevention
Summary
To prevent recurrence of invasive fungal infection in patients with allogeneic stem cell transplants
Timeline
- Start
- 2005-02
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voriconazole | Small molecule | — | — |